Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Engelsman

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Clinical Biochemistry|March 1, 1970
Serum 5'-nucleotidaseW van der Slik, J P Persijn, E Engelsman, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1985
Combined cytotoxic and endocrine therapy in postmenopausal patients with advanced breast cancer. A randomized study of CMF vs CMF plus tamoxifenH T Mouridsen, C Rose, E Engelsman, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1985
Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical studyC Schaake-Koning, E H van der Linden, G Hart, et al.
Lancet (London, England)|March 16, 1974
Plasma-prolactin in human breast cancerH G Kwa, M De Jong-Bakker, E Engelsman, et al.
Cancer|March 15, 1991
Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatmentW Boogerd, A A Hart, J J van der Sande, et al.
European Journal of Cancer|January 1, 1980
A phase II study of Mitomycin C in refractory adcvanced breast cancer. A multi-centre pilot studyA T van Oosterom, T J Powles, E Hamersma, et al.
European Journal of Cancer|January 1, 1980
Life with cytostatic drugsF S Van Dam, A C Linssen, E Engelsman, et al.
European Journal of Nuclear Medicine|January 1, 1987
The role of I-131-MIBG in the diagnosis and therapy of carcinoidsC A Hoefnagel, F C den Hartog Jager, B G Taal, et al.
Breast Cancer Research and Treatment|January 1, 1984
Pros and cons of aminoglutethimide for advanced postmenopausal breast cancerP F Bruning, J G Bonfrèr, E Engelsman, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 16, 1988
[Diagnosis and therapy of neural crest tumors using I131 iodobenzylguanidine]C A Hoefnagel, J de Kraker, P A Voûte, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Clinical Biochemistry|March 1, 1970
Serum 5'-nucleotidaseW van der Slik, J P Persijn, E Engelsman, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1985
Combined cytotoxic and endocrine therapy in postmenopausal patients with advanced breast cancer. A randomized study of CMF vs CMF plus tamoxifenH T Mouridsen, C Rose, E Engelsman, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1985
Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical studyC Schaake-Koning, E H van der Linden, G Hart, et al.
Lancet (London, England)|March 16, 1974
Plasma-prolactin in human breast cancerH G Kwa, M De Jong-Bakker, E Engelsman, et al.
Cancer|March 15, 1991
Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatmentW Boogerd, A A Hart, J J van der Sande, et al.
European Journal of Cancer|January 1, 1980
A phase II study of Mitomycin C in refractory adcvanced breast cancer. A multi-centre pilot studyA T van Oosterom, T J Powles, E Hamersma, et al.
European Journal of Cancer|January 1, 1980
Life with cytostatic drugsF S Van Dam, A C Linssen, E Engelsman, et al.
European Journal of Nuclear Medicine|January 1, 1987
The role of I-131-MIBG in the diagnosis and therapy of carcinoidsC A Hoefnagel, F C den Hartog Jager, B G Taal, et al.
Breast Cancer Research and Treatment|January 1, 1984
Pros and cons of aminoglutethimide for advanced postmenopausal breast cancerP F Bruning, J G Bonfrèr, E Engelsman, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 16, 1988
[Diagnosis and therapy of neural crest tumors using I131 iodobenzylguanidine]C A Hoefnagel, J de Kraker, P A Voûte, et al.
Pageof 4